Trial Profile
Effect of eltrombopag given after romiplostim in Spanish patients with chronic immune thrombocytopenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2015
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.
- 22 May 2015 New trial record